Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
1246
Corynebacterium striatum Meningitis: Case Report and Review of an Increasingly Important Corynebacterium Species
K. Weiss, A. C. Labbe, and M. Laverdiere From the Department of Microbiology and Infectious Diseases, H6pital Maisonneuve-Rosemont, University of Montreal, Montreal,
Quebec, Canada
For a long time, corynebacteria were considered simple cutaneous contaminants with little potential pathogenicity. Corynebacterium striatum is a known saprophytic cutaneous bacterium; however, in the last decade, this organism has been increasingly recognized as a pathogen. It has been mostly implicated in respiratory tract and blood infections. To our knowledge, we report the first case of meningitis due to C. striatum. Treatment with intravenous vancomycin resulted in therapeutic success. We also thoroughly review all previously reported cases of C. striatum infection. Identification of Corynebacterium species can be difficult because of rapid taxonomic changes, and susceptibility testing for these microorganisms is not yet standardized. However, because of their growing clinical importance, data on these bacteria are accumulating.
Corynebacterium species are part of the normal skin flora; these microorganisms are also found in the environment or in animals [1]. For a long time, they were considered simple cutaneous contaminants with little or no potential pathogenicity. However, during the last decade, Corynebacteriumjeikeium and Corynebacterium urealyticum have been implicated in infectious processes, especially catheter-related infections and urinary tract infections [2]. These species are characterized by their multiresistant susceptibility profile, which makes them unique among Corynebacterium species. The taxonomy of Corynebacterium species is rapidly changing and is still not completely established. Numerous Corynebacterium species have been recently reclassified as members of the coryneform group, and taxonomic modifications are still being made [1].
Corynebacterium striatum has not been considered a potentially pathogenic microorganism until recently. When this organism was found in clinical specimens, it was often discarded as a contaminant. Its taxonomic classification is not yet very clear. Several case reports of C. striatum infection have been published; however, most of these cases were blood infections [3-8] or respiratory tract infections [9-12]. To our knowledge, we report the first proven case of meningitis caused by C. striatum. Moreover, we review the previously reported cases of infection due to this increasingly important emerging pathogenic species of Corynebacterium.
Case Report
A 23-year-old man with no underlying medical problem presented to the emergency department of our hospital on 29
Received 2 May 1996; revised 24 June 1996. Reprints or correspondence: Dr. K. Weiss, Hopita1 Maisonneuv~-Rosemont,
5415 L'Assomption, Montreal, Quebec, Canada HIT 2M4.
Clinical Infectious Diseases 1996; 23:1246-8 © 1996 by The University of Chicago. All rights reserved. 1058--4838/96/2306-0023$02.00
November 1995 complaining of headache, nausea, vomiting, and photophobia. In May 1995, the patient had had a major motorcycle accident in which he sustained a fracture of the right humerus that was complicated by avulsion of nerve roots from C-6 to T -1. He subsequently had pseudomeningocele and paralysis ofthe right arm; he underwent extensive nerve reconstructive surgery on 16 November 1995. A drain was left in place at that time, and a persistent leak was present. The patient's condition following his surgery was favorable, and he was discharged on 20 November 1995. A few days later, he started complaining of an increasingly painful headache that was occasionally accompanied by chills.
At the time of admission, the patient was alert and well oriented and had a severe headache; his oral temperature was 38.5°C, and his vital signs were normal. Neurological examination showed a stiff neck and right arm paralysis. Physical examination was otherwise unremarkable, and there was no infection at the surgical site. However, there was a leak of cloudy fluid through a cutaneous fistula, which was likely in communication with the CSF; the drain was immediately removed.
Laboratory tests of blood taken at admission showed a WBC count of 21.3 X 109/L with 94% polymorphonuclear leukocytes. A lumbar puncture yielded cloudy CSF; analysis of CSF revealed a decreased glucose concentration of 1.5 mmollL (normal value, 2.8-3.9 mmollL), an increased protein concentration of 4.35 gIL (normal value, 0.15-0.4 giL), and an elevated WBC count of 1131 ilL (92% neutrophils). Gram staining of CSF demonstrated the presence of coccobacillary grampositive bacteria. Intravenous ceftriaxone (1 g every 12 hours) and intravenous vancomycin (1 g every 12 hours) were immediately administered to the patient. Two cultures of blood taken before the start of antibiotic therapy remained negative.
After a 24-hour incubation period, culture of a CSF specimen subsequently yielded pure growth of a gram-positive rod. The microorganism had a beige appearance, was catalase-positive, reduced nitrate, and was nonmotile. After 48 hours, the colony's diameter was about 2-3 mm, and it had a creamy texture.
cm 1996;23 (December) Corynebacterium striatum Meningitis 1247
Table 1. Summary of data on reported cases of Corynebacterium striatum infection.
Year of publication Patient's Predisposing [reference] age (y)/sex Disease condition(s) Therapy Outcome
1980 [9] 791M Pneumonia Chronic lymphocytic Carbenicillin Died leukemia
1986 [10]* 221M Empyema Multiple trauma ND Alive 1989 [3]t 641F Septicemia Endometrial Ampicillin, gentamicin Alive
carcinoma, recent chemotherapy
1990 [4] 761M Endocarditis None Ampicillin, gentamicin Died 1991 [16] 801F Keratitis Diabetes, glaucoma Cefazolin, tobramycin Alive 1993 [5] 191M Blood infection Lymphoma, BMT Vancomycin, amikacin Alive 1993 [5] 461F Catheter site Myelodysplasia, BMT Vancomycin, Alive
infection tobramycin, mezlocillin
1993 [5] 3lIF Uterus Pregnant (28 w) Ampicillinlsulbactam Alive infection
1993 [11] 691M COPD COPD Amoxicillin Alive exacerbation
1994 [12] 271M Pneumonia Alcoholism Vancomycin Died 1994 [6] 261M Bacteremia AIDS, IV drug user Teicoplanin Alive
1994 [7] 541M Aortic valve Right elbow abrasion Ampicillin, Alive
endocarditis vancomycin, valve replacement
1995 [15] 531M CAPD Chronic renal failure Vancomycin, Alive
peritonitis ceftazidime
1996 [8] 731M Endocarditis Pacemaker Vancomycin Alive
1996 [PRJ 231M Meningitis CSF-skin fistula Vancomycin Alive
NOTE. BMT = bone marrow transplant; CAPD = continuous ambulatory peritoneal dialysis; COPD = chronic obstructive pulmonary disease; ND = not done; PR = present report.
* C. striatum was a possible cause. t The strain's identification was controversial.
The bacterium was subsequently identified as C. striatum by using the API-Coryne system (bioMerieux, Marcy I 'Etoile, France); the identification was categorized as good (identification code, 3100105; % id = 97.1; T index = 1). The strain's identification was confirmed by the Quebec Provincial Laboratory (Ste. Anne de Bellevue, Quebec, Canada) by means of conventional methods. Susceptibility testing was performed by a broth microdilution technique with cation-adjusted MuellerHinton broth supplemented with 4.5% lysed horse blood agar and 6.6% rabbit serum. Plates were incubated under aerobic conditions for 48 hours [l3]. With use of the criteria of the National Committee for Clinical Laboratory Standards [14], the bacterium was found to be susceptible to vancomycin (MIC, ~0.125 mglL) and erythromycin (MIC, ~0.016 mglL) and intermediately susceptile to penicillin (MIC, 0.25 mg/L).
Ceftriaxone therapy was discontinued after 24 hours, whereas vancomycin therapy was continued for a total of 10 days. After 48 hours of treatment, we noted a marked improvement in the patient's condition; he became afebrile, and his headache almost completely disappeared. In the meantime, the leak progressively stopped, and it completely ceased on 9 December 1995. A culture of leaking fluid obtained 5 days after admission yielded no bacterial growth. A control lumbar punc-
ture was not done, and the CSF level of vancomycin was not measured. On 12 December 1995, the patient was discharged in excellent condition; there were no new neurological sequelae, and he was not receiving any antibiotic therapy. At a I-month follow-up at the outpatient clinic, he was perfectly well.
Discussion
For a long time, C. striatum was considered a saprophytic bacterium colonizing the anterior nares and skin; it seemed to be isolated more often from sites on the upper part of the body. However, during the last few years, several cases of definite infection caused by this microorganism have been reported. The first case report describing this bacterium as a pathogenic microorganism was published in 1980 [9]. This case involved pulmonary infection in an immunocompromised host. Infections in the other reports almost always were associated with underlying medical problems. Most cases of C. striatum infection occurred in either immunocompromised patients or patients whose skin barrier integrity was broken. C. striatum was mainly recovered from either blood (six cases) or respiratory
1248 Weiss, Labbe, and Laverdiere CID 1996;23 (December)
tract specimens (four cases). A total of 15 cases, including ours, have been reported (table 1).
Previous reports have not implicated C. striatum in CNS infection, and this case confirms that this bacterium has the potential to cause meningitis. The fact that there was direct communication between the skin and the CSF through a catheter left in place following the initial surgery could explain the pathogenesis of this particular infection. This bacterium has also caused chronic peritonitis associated with ambulatory peritoneal dialysis [15] as well as keratitis [16].
C. striatum is a Corynebacterium species that can be difficult to identify in certain circumstances, and sometimes it can be confused with Corynebacterium xerosis. These two bacteria can be differentiated by maltose utilization [1]. However, C. xerosis seems to be much more resistant to erythromycin [13, 17, 18]. Colonies of C. striatum are white, tan, or yellowish and grow well on sheep blood agar, and individual cells are rather large compared with the other Corynebacterium species. The bacterium is named after the stripes often observed during gram staining.
Susceptibility testing for Corynebacterium species is still a controversial issue for which there are no clear recommendations or guidelines [13, 17, 18]. We used the criteria for Streptococcus for interpreting susceptibility to penicillin, because in a previous study [13] we found that to avoid major errors these criteria are more appropriate than those for Listeria (the only gram-positive rod for which susceptibility criteria are available).
Our patient was successfully treated with vancomycin, but this antibiotic penetrates the CSF poorly when there is no inflammation. However, vancomycin can reach an acceptable level when there is inflammation of the meninges. There are some controversial data regarding inflammation and diffusion of vancomycin in the CSF. Some investigators [19] found that 18% of the initial dose could penetrate the CSF in cases of meningitis, while other investigators found an unacceptably high level of therapeutic failure in cases of meningitis due to penicillin-resistant pneumococci [20]. G1ycopeptides (vancomycin or teicop1anin) were prescribed in most of the cases, but therapeutic success was also achieved with ampicillin. MICs of penicillin for C. striatum often range from 0.25 to 1 mg/L, whereas all strains are susceptible to vancomycin [13, 17].
C. striatum is being increasingly described as a pathogenic Corynebacterium species, and its presence in clinical specimens should not always be overlooked, especially in samples from patients with underlying medical conditions. Moreover, until definitive results of susceptibility testing are available, vancomycin is the recommended treatment for severe infections due to Corynebacterium species [17, 18].
References
1. Clarridge JE, Spiegel CA. Corynebacterium and miscellaneous irregular
Gram-positive rods, Erysipelothrix, and Gardnerella. In: Murray PR,
Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical
microbiology. 6th ed. Washington, DC: American Society for Microbi
ology, 1995:357-78.
2. Coyle MB, Lipsky BA. Coryneform bacteria in infectious diseases: clinical
and laboratory aspects. Clin Microbiol Rev 1990;3:227-46.
3. Dall L, Barnes WG, Hurford D. Septicaemia in a granulocytopenic patient
caused by Corynebacterium striatum. Postgrad Med J 1989;65:247-8.
4. Markowitz SM, Coudron PE. Native valve endocarditis caused by an
organism resembling Corynebacterium striatum. J Clin Microbiol1990;
28:8-10.
5. Watkins DA, Chahine A, Creger RJ, Jacobs MR, Lazarus HM. Corynebac
terium striatum: a diphtheroid with pathogenic potential. Clin Infect
Dis 1993; 17:21-5.
6. Tumbarello M, Tacconelli E, Del Forno A, Caponera S, Cauda R. Coryne
bacterium striatum bacteremia in a patient with AIDS [letter]. Clin
Infect Dis 1994; 18:1007-8.
7. Rufael DW, Cohn SE. Native valve endocarditis due to Corynebacterium
striatum: case report and review. Clin Infect Dis 1994; 19:1054-61.
8. Melero-Bascones M, Munoz P, Rodriguez-Creixems M, Bouza E. Coryne
bacterium striatum: an undescribed agent of pacemaker-related endocar
ditis [letter]. Clin Infect Dis 1996;22:576-7.
9. Bowstead TT, Santiago SM. Pleuropulmonary infection due to Corynebacterium striatum. Br J Dis Chest 1980;74:198-200.
10. Barr JG, Murphy PG. Corynebacterium striatum: an unusual organism
isolated in pure culture from sputum [letter]. J Infect 1986; 13:297-8.
II. Cowling P, Hall 1. Corynebacterium striatum: a clinically significant
isolate from sputum in chronic obstructive airways disease [letter]. J
Infect 1993; 26:335-6.
12. Martinez-Martinez L, Suarez AI, Ortega MC, Rodriguez-Jimenez R. Fatal
pulmonary infection caused by Corynebacterium striatum [letter]. Clin
Infect Dis 1994; 19:806-7.
13. Weiss K, Laverdiere M, Rivest R. Comparison of antimicrobial susceptibil
ities of Corynebacterium species by broth microdilution and disk diffu
sion methods. Antimicrob Agents Chemother 1996;40:930-3.
14. National Committee for Clinical Laboratory Standards. Methods for dilu
tion antimicrobial susceptibility tests for bacteria that grow aerobically:
approved standard. 3rd ed. NCCLS document M7-A3. Villanova, Penn
sylvania: National Committee for Clinical Laboratory Standards, 1993.
15. Bhandari 8, Meigh JA, Sellars 1. CAPD peritonitis due to Corynebacte
rium striatum [letter]. Perit Dial Int 1995; 15:88-9.
16. Heidemann DG, Dunn SP, Diskin JA, Aiken TB. Corynebacterium stria
tum keratitis. Cornea 1991; 10:81-2.
17. Soriano F, Zapardiel J, Nieto E. Antimicrobial susceptibilities of Coryne
bacterium species and other non-spore-forming gram-positive bacilli to
18 antimicrobial agents. Antimicrob Agents Chemother 1995;39:
208-14.
18. Williams DY, Selepak ST, Gill VJ. Identification of clinical isolates of
nondiphtherial Corynebacterium species and their antibiotic susceptibil
ity patterns. Diagn Microbiol Infect Dis 1993; 17:23-8.
19. Schaad UB, Nelson JD, McCracken GH JI. Pharmacology and efficacy of
vancomycin for staphylococcal infections in children. Rev Infect Dis
1981;3(suppl 1):8282-8.
20. Viladrich PF, Gudiol F, Linares J, et al. Evaluation of vancomycin for
therapy of adult pneumococcal meningitis. Antimicrob Agents Chemo
ther 1991;35:2467 -72.